Scientists at The Institute of Cancer Research have developed a method to identify bowel cancer patients most likely to ...

Harrow's fair value of $73.25 implies 104% upside from current levels. Click here to see why the stock is a Buy.

New AI method predicts which patients with advanced bowel cancer are unlikely to respond to the targeted drug bevacizumab – a drug recently approved for use on the NHS.There are limited treatment ...

Scientists have developed a new AI model to identify which cancer patients would respond best to a targeted drug on the NHS.

Quantum key distribution (QKD) has been positioned as a physics-based method of securing encryption keys that cannot be ...

In just a few short weeks, thousands of Grade 12 pupils will be sitting for their June matric exams. Try these study tips for ...

Early voting data from Virginia suggests Democrats have an advantage in their push to enact a gerrymander that could net them ...

Scientists develop AI tool to predict how cancer patients will respond to NHS drug - New PhenMap tool helps to spot patterns ...

Yuancheng Ryan Lu could barely breathe while he waited for his labmate to adjust the microscope focus. On the slide in front ...

Diversified portfolios outperformed the 60/40 model in 2025, but long-term results show traditional strategies deliver better ...

A proposal for women’s reservation in Lok Sabha that ensures 33 per cent seats while also being the least cumbersome to ...

As more states legalize recreational marijuana use, here’s what the research says about what cannabis is really doing to your ...